investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Development of a Genomic Expression Signature Associated with Chemoresistance
Douglas C Marchion
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Douglas C Marchion
Moffitt Cancer Center
Tampa, United States
Related projects
William G Cance
Focal Adhesion Kinase - Tumor Biology and Therapeutics
Breast
Thomas Ried
Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer
Breast
Carol A Lange
Inducible PTK6 expression drives oncogenic signaling in breast cancer
Breast
Gregory Longmore
Novel Small Molecule Inhibition of DDR2 to Prevent Breast Cancer Metastasis
Breast
Jeffrey W. Pollard
The Metastatic Cascade: Macrophages Lead the Way
Breast
Powel Brown
VADIS TRIAL: PHASE II TRIAL OF E75 PEPTIDE VACCINE IN WOMEN WITH DCIS OF THE BREAST
Breast
Thomas Spies
Stimulation of Tumorigenesis by NKG2D
Breast
Pathology
Fraser Symmans
Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer
Breast
Calvin J Kuo
miR-126 Regulation of Tumor Progression
Breast